Cite
HARVARD Citation
Gergely, T. et al. (2023). Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment. British journal of pharmacology. pp. 740-761. [Online].